Smart Biosensors Market Type, Product, Key Players, Application and Growth Forecast to 2030| MRFR
Smart
Biosensors Market Highlights
Smart
biosensors are medical devices used for chemical and biological analysis of a
human body or any biological substance. Smart biosensors are advance and more
effective than other traditional sensors. The increasing prevalence of
diabetes in emerging economies, demand for advanced monitoring systems, and
increasing awareness about advance biosensors are the major factors
driving the growth of the global smart biosensors market. According to the
International Diabetic Federation, about 415 million people across the globe
were reported to have diabetes in 2015, and this number is expected to reach
642 million by 2040. It also stated that 98.4 million and 65.1 million diabetic
population lived in China and India respectively.
The Smart Biosensors market
is anticipated to reach USD 23819.88 Million by 2030 at 6.90% CAGR during the
forecast period 2022-2030.
The rising
cost of biosensors and unfavourable reimbursement policies may
hamper market growth during the forecast period.
Segmentation
The
global smart biosensors market report
has been segmented based on product type, technology, application, and end
user.
Based
on product type, the market has been classified as wearable biosensors,
non-wearable biosensors.
The
technology segment has been divided into electrochemical biosensors,
piezoelectric biosensors, optical biosensors, thermal biosensors,
nanomechanical biosensors, and others. thermal biosensors segment is likely to
be the fastest growing segment during the forecast period.
Based
on application, has been segmented into blood glucose testing, cholesterol
testing, blood gas analysis, pregnancy testing, drug discovery, infectious
disease testing, and others.
The end
user segment has been divided into point-of-care, home diagnostics, research labs,
security & biodefense, environmental monitoring, food & beverage
industry, and others.
Regional
Analysis
The
Americas are likely to dominate the global smart biosensors market due to
the rising prevalence of chronic disorders, favourable policies
implemented by government and regulatory authorities, and the adoption of
highly advanced technology. The European market is expected to be the
second-largest smart biosensors market. The presence of well-established
healthcare system in the region, government initiatives for controlling chronic
disorders, and increase in a population suffering from cardiovascular
disorders are the factors responsible for the growth of the smart
biosensors market in the region. Asia-Pacific is anticipated to be the
fastest-growing smart biosensors market during the forecast period owing to
the increasing prevalence of diabetes, increasing disposable income, and
government initiatives for the development of the healthcare sector. The market
in the Middle East & Africa is likely to account for the smallest share of
the global smart biosensors market.
Key
Players
The
global smart biosensors market Players are Abbott Point of Care Inc., Medtronic
Inc., F. Hoffman La-Roche Ltd., Siemens Healthcare AG, Lifescan, Inc.,
LifeSensors Inc., Nova Biomedical Corp., Acon Laboratories Inc., Universal
Biosensors, Pharmaco-Kinesis Corporation, Biacore, and others.
About Market Research Future:
At Market Research Future (MRFR), we enable
our customers to unravel the complexity of various industries through our
Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), &
Consulting Services. MRFR team have supreme objective to provide the optimum
quality market research and intelligence services to our clients.
Contact us:
Market Research Future (part of Wantstats
Research and Media Private Limited),
99 Hudson Street, 5Th Floor,
New York, New York 10013
United States of America
+1 628 258 0071
Email: sales@marketresearchfuture.com
Comments
Post a Comment